Byoung-Ok Ahn

Title: Byoung-Ok Ahn: Innovator in Pharmaceutical Chemistry

Introduction

Byoung-Ok Ahn is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating various medical conditions. With a total of 2 patents to his name, Ahn's work reflects a commitment to advancing healthcare solutions.

Latest Patents

Ahn's latest patents include innovative compounds such as 1,3-dihydro-5-isobenzofurancarbonitrile derivatives. These derivatives are designed for the treatment of premature ejaculation. The invention discloses novel compounds that selectively inhibit serotonin reuptake, thereby providing a therapeutic approach to managing this condition. Another significant patent involves 3',4',5-trimethoxy flavone derivatives, which serve as stimulants for mucus secretion. This invention is particularly relevant for treating dry eye syndrome, as it demonstrates the ability to inhibit corneal damage through enhanced mucus secretion in the conjunctiva.

Career Highlights

Throughout his career, Ahn has worked with reputable companies such as Dong-A Pharmaceutical Co., Ltd. and Dong-A Pharm. Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical research.

Collaborations

Ahn has collaborated with notable colleagues, including Mi-Jeong Seo and Kyung-Koo Kang. These partnerships have contributed to the successful development of his patented inventions.

Conclusion

Byoung-Ok Ahn's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key figure in the field. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in healthcare.